Company Overview and News

 
These Chinese Junk Bond Issuers Are at Risk if the Yuan Falls 10% - Bloomberg

2017-02-27 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

 
Moody’s Says It Didn’t Breach Hong Kong Rules in Appeal Case - Bloomberg

2017-01-11 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

 
Hong Kong regulatory ruling not appropriate, Moody’s tells court

2017-01-11 theedgemarkets
(Jan 11): Moody’s Investors Service did not breach Hong Kong’s regulatory code of conduct because it never used a 2011 report on listed companies as a credit-rating tool, the city’s High Court heard Wednesday during an appeal hearing.

 
Appointment of Finance Director

2016-08-09 londonstockexchange
Aquatic Foods Group Plc (AIM: AFG), a leading Chinese marine foods and seafood processor and producer, supplying to export and local markets, is pleased to announce the appointment of Ms Po Ling Low as Finance Director.

 
UPDATE 1-West China Cement shares plunge after Anhui Conch scraps deal

2016-07-04 reuters
* 24 pct share decline follows steep share slide last week (Recasts and adds analyst comment)

 
West China Cement shares plunge after Anhui Conch scraps deal

2016-07-04 reuters
HONG KONG, July 4 Shares in West China Cement Ltd fell as much as 35 percent on Monday after larger rival Anhui Conch Cement Co Ltd scrapped a planned takeover of the Hong Kong-listed firm.

 
China cement deal collapses amid oversupply woes

2016-07-01 financialexpress
A deal for China’s largest cement maker to take over a major rival collapsed after failing to gain government approval, the company said today, in a blow to Beijing’s pledges to tackle oversupply.

 
Fast FT — FT.com

2016-06-28 on.ft
Vodafone has signaled that it could consider moving its headquarters out of the UK given uncertainty about how many of the “positive attributes” of being in the EU will remain once Britain has exited the bloc.

 
Moody's fined HK$11m as Hong Kong tribunal sides with SFC

2016-04-01 businesstimes.com.sg
[HONG KONG] Moody's Investors Service must pay an HK$11 million (S$1.91 million) penalty after a Hong Kong tribunal upheld an action against the firm by the city's financial regulator.

Related Articles

SGMO: Sangamo BioSciences and Research Report

2018-05-19 - Asif

OVERVIEW Sangamo BioSciences is a clinical stage biotechnology company focused on translating ground-breaking science into genomic therapies that transform patients’ lives using its industry-leading platform technologies in genome editing, gene therapy, gene regulation and cell therapy. Sangamo BioSciences is a leader in the research and development of zinc finger proteins, or ZFPs, a naturally occurring class of proteins found in humans. Sangamo BioSciences has used its knowledge and expertise to develop a proprietary technology platform in both genome editing and gene regulation. ZFPs can be engineered to make zinc finger nucleases, or ZFNs, proteins that can be used to specifically modify DNA sequences by adding or knocking out specific genes, or genome editing, and ZFP transcription factors or ZFP TFs, proteins that can be used to increase or decrease gene expression, or gene regulation. In the process of developing this platform, Sangamo BioSciences has accrued signific...

HMNY: Helios and Matheson Analytics and Research Report

2018-05-19 - Asif

Business Overview The company provide high quality information technology, or IT, services and solutions including a range of technology platforms focusing on big data, business intelligence, and consumer-centric technology. More recently, to provide greater value to stockholders, the Company has sought to expand its business primarily through acquisitions that leverage its capabilities and expertise. As of March 31, 2018, the Company owned 81.2%, and as of the date of this report the Company owns 91.8%, of the outstanding shares of MoviePass (excluding outstanding MoviePass options and warrants). MoviePass is the premiere movie theater subscription service in the United States which provides its subscribers the ability to view up to one new movie title per day for one monthly subscription price. The company's more than 2 million subscribers have access to see films in over 91% of U.S movie theaters. By the end of April 2018, the company implemented certain measures ...

BSTG: Biostage Analysis and Research Report

2018-05-17 - Asif

Overview Biostage is a biotechnology company developing bioengineered organ implants based on its novel CellframeTM technology. The company's Cellframe technology is comprised of a biocompatible scaffold that is seeded with the recipient’s own stem cells. This technology is being developed to treat life-threatening conditions of the esophagus, trachea or bronchus with the objective of dramatically improving the treatment paradigm for those patients. The company believe that its Cellframe technology will provide surgeons with new ways to address damage to the esophagus, bronchus, and trachea due to congenital abnormalities, cancer, infection or trauma. Products being developed based on its Cellframe technology for those indications are called CellspanTM products. The company announced favorable preliminary pre-clinical results of large-animal studies for the esophagus, trachea and bronchus in November 2015. Since then, the Cellspan esophageal implant product candidates hav...